Featured,Spotlight Stock,Trends & Articles PharmaDrug Granted FDA Orphan Drug Designation of DMT for Prevention of Ischemia-Reperfusion Injury During Organ Transplant By Dennis Mutua April 29, 2021 Biotechnology company focused on development and commercialization of natural medicine and controlled substances including cannabis and psychedelics PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) announced having been granted U.S. Food ...
Psychedelic Stocks,Shroom News Delix Therapeutics Releases Study Results Showing Therapeutic Potential for a Psychedelic Analogue Without Hallucinogenic Effects By Dennis Mutua April 29, 2021 Preclinical pharmaceutical company developing small molecule drug compound intended to assist providing therapies for mental illness patients Delix Therapeutics released results of a highly regarded scientific study. According ...
Psychedelic Stocks,Shroom News COMPASS Pathway Launches Public Offering of 4M American Depositary Shares By Dennis Mutua April 28, 2021 Mental healthcare company COMPASS Pathways PLC (CMPS) has launched a proposed public offering of 4 million American Depositary Shares (ADSs). Each of these ADSs will be representing one ordinary share of the company. In additio...
Featured,Spotlight Stock,Trends & Articles PharmaTher Files For a Provisional Patent for Using Ketamine to Treat Diabetes and Obesity By Dennis Mutua April 28, 2021 Psychedelics Pharmaceutical company specializing in research, development and distribution of psychedelics PharmaTher Ther. (CSE: PHRM) (OTCQB: PHRRF) has filed for a provisional patent with the United States Patent and Trademark ...
Psychedelic Stocks,Shroom News PsyBio and Miami University Extend Partnership For Extended Neuropsychiatric Drug Discovery By Dennis Mutua April 27, 2021 Therapeutics company developing biosynthetic psychoactive compounds for treatment of mental conditions PsyBio Therapeutics Corp. (CVE: PSYB) has extended its sponsored partnership agreement with Ohio based Miami University. The...
Featured,Spotlight Stock,Trends & Articles MindMed Goes Public Becoming Second U.S Public Psychedelics Company By Dennis Mutua April 27, 2021 Biotechnology company engaging in developing and deploying psychedelics infused drugs to treat mental conditions Mind Medicine (MindMed) Inc. is set to start trading on NASDAQ on April 27 making it the second United States psyched...
Psychedelic Stocks,Trends & Articles Champignon Announces Revocation of Cease Trade Orders by Markets Regulators By Dennis Mutua April 26, 2021 Medical solutions company focused on mental illnesses and disorders with emphasis on psychedelics medicine Champignon Brands Inc. (CNSX: SHRM) (OTCQB: SHRMF) announced a cease trade order having been revoked by the Ontario Securit...
Featured,Shroom News Cambridge Health Alliance and Harvard Medical School Offering Training on Psychedelics By Dennis Mutua April 26, 2021 Innovative healthcare system Cambridge Health Alliance (CHA) and Harvard Medical School will be offering a continuing education course on psychedelics titled “Meditation and Psychotherapy: Learning from Non-Ordinary States”. ...